Cardiff Oncology
CRDF
CRDF
110 hedge funds and large institutions have $76.6M invested in Cardiff Oncology in 2025 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 26 increasing their positions, 33 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 112 → 110 (-2)
21% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 33
Holders
110
Holding in Top 10
1
Calls
$2.08M
Puts
$284K
Top Buyers
| 1 | +$2.8M | |
| 2 | +$1.21M | |
| 3 | +$800K | |
| 4 |
Two Sigma Advisers
New York
|
+$777K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$490K |
Top Sellers
| 1 | -$615K | |
| 2 | -$430K | |
| 3 | -$276K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$266K |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$265K |
